Presentation with the occasion of the Technical Briefing at World Halth Assembly, Geneva, 18 May 2011
Citation preview
1. UNITAID approach to working in markets to improve public
health Technical Briefing World Health Assembly, Geneva 18 May,
2011 Brenda Waning
2. Session Agenda
Brief overview of UNITAID: why and how UNITAID works through
markets to improve public health
Key highlights of UNITAIDs portfolio to date: proof of concept
that market approaches work
New opportunities for market interventions to improve
health
Trends in organizations moving to adopt market approaches:
presentations from other stakeholders
3. UNITAID: a WHO Partnership moving markets Partners Working
towards the common goal of expanding access to health
Est. 2006: Innovative finance mechanism based largely on air
tax levies from north & south
Geneva-based
secretariat: no in-country offices work with partners
First and only UN organization to work exclusively through
markets to improve public health
HIV/AIDS, TB, malaria
4. UNITAID Goal Healthy markets, healthy people UNITAID aims to
promote healthy, dynamic market conditions whereby manufacturers
have incentives to invest and innovate , while at the same time
supply quality public health products at affordable prices and in
acceptable formulations that enable the maximum number of people to
access them.
5. What is a market?
6. Market impact framework UNITAID Intervention example: 2 nd
line ARV market
7. How UNITAID intervenes
UNITAIDs role depends upon the particular circumstances in a
given market:
Market catalyst: identifying and facilitating adoption and
uptake of new and/or superior public health products;
Market creator: providing incentives for manufacturers to
produce otherwise unattractive products with low demand that yield
little profit but substantial public health benefit to those in
need; and
Market fixer: addressing severe market inefficiencies (e.g.
grossly inaccurate demand forecasts and excessive transaction
costs) that contribute to low access to quality-assured public
health products.
8. UNITAID examples (a few)
Market catalyst:
Second-line ARV (& tenofovir) programs
Expand TB (diagnostic line probe assay)
Market creator:
Paediatric programs for HIV/AIDS & TB
Affordable Medicines Facility for Malaria (AMFm)
Market "fixer":
WHO Prequalification of Medicines Programme
Medicines patent pool
Strategic rotating stockpile for TB medicines
ACT Forecasting
Market intelligence systems
9. Market intelligence: the GPS of market interventions Used to
locate "global positions" around interventions before & after
implementation UNITAID accounts for > 90% market for paediatric
ARVs in fixed-dose combination form, 2009* 90% pediatric &
adult 1 st line ARVs made by Indian generic producers, 2008 *
10. New opportunities: the Decade of Diagnostics
Unprecedented innovation in diagnostics technology
Better chemistry, simpler to use, more affordable
Finally will be able to bring diagnostics to people and regions
previously underserved
Xpert MTB
Dramatic breakthrough in lab-based tuberculosis diagnostic
technology
Malaria Rapid Diagnostic Tests
From labs (microscopes) to homes (disposable Point of Care
tests)
HIV CD4 and Viral Load
From central labs to clinics (Point of Care tests)
11. CD4 Product Pipeline*
12. Viral Load & EID Product Pipeline*
13. UNITAID is one of several players working to keep markets
in balance to improve public health
UNITAID showed proof of concept: market interventions have
substantial, long term impact far beyond country recipients
Many others now adopting market approaches: coordination &
collaboration to leverage relative strengths & maximize use of
resources towards achieving collective public health goals
